Shares of Thermo Fisher Scientific Inc (TMO) Rally 2.85%

Thermo Fisher Scientific Inc (TMO) : Traders are bullish on Thermo Fisher Scientific Inc (TMO) as it has outperformed the S&P 500 by a wide margin of 2.89% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 1.33%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 2.85% in the last 1 week, and is up 7.39% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock. The stock has recorded a 20-day Moving Average of 5.34% and the 50-Day Moving Average is 4.99%.

Thermo Fisher Scientific Inc (NYSE:TMO): The stock opened at $158.37 on Friday but the bulls could not build on the opening and the stock topped out at $158.37 for the day. The stock traded down to $156.75 during the day, due to lack of any buying support eventually closed down at $157.04 with a loss of -0.44% for the day. The stock had closed at $157.73 on the previous day. The total traded volume was 1,628,209 shares.


The company Insiders own 0.52% of Thermo Fisher Scientific Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -4.39% . Institutional Investors own 90.9% of Thermo Fisher Scientific Inc shares. During last six month period, the net percent change held by insiders has seen a change of -8.52%. In a related news,The officer (Senior Vice President) of Thermo Fisher Scientific Inc., Loewald Thomas W sold 8,025 shares at $155 on July 13, 2016. The Insider selling transaction had a total value worth of $1,243,875. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.